{"indexed":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T13:23:27Z","timestamp":1556630607505},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1573,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1742-1241.2011.02655.x","type":"article-journal","created":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T02:05:02Z","timestamp":1305252302000},"page":"679-683","source":"Crossref","is-referenced-by-count":26,"title":"Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study","prefix":"10.1111","volume":"65","author":[{"given":"P.","family":"Anagnostis","sequence":"first","affiliation":[]},{"given":"D.","family":"Selalmatzidou","sequence":"additional","affiliation":[]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"A.","family":"Panagiotou","sequence":"additional","affiliation":[]},{"given":"A.","family":"Slavakis","sequence":"additional","affiliation":[]},{"given":"A.","family":"Panagiotidou","sequence":"additional","affiliation":[]},{"given":"V. G.","family":"Athyros","sequence":"additional","affiliation":[]},{"given":"A.","family":"Karagiannis","sequence":"additional","affiliation":[]},{"given":"D. P.","family":"Mikhailidis","sequence":"additional","affiliation":[]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,5,12]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138945010790030992","article-title":"Should adipokines be considered in the choice of the treatment of obesity-related health problems?","volume":"11","author":"Athyros","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"9","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1074248409357922","article-title":"Effects of atorvastatin 20\u2003mg, rosuvastatin 10\u2003mg, and atorvastatin\/ezetimibe 5\u2003mg\/5\u2003mg on lipoproteins and glucose metabolism","volume":"15","author":"Her","year":"2010","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3904\/kjim.2010.25.1.27","article-title":"Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia","volume":"25","author":"Park","year":"2010","journal-title":"Korean J Intern Med"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1440-1681.2008.04945.x","article-title":"Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients","volume":"35","author":"Ando","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0029-1220770","article-title":"Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: a prospective, randomized study","volume":"118","author":"Kaya","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2008.09.021","article-title":"Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients","volume":"204","author":"Koh","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1515\/CCLM.2010.303","article-title":"Effect of homeostasis model assessment computational method on the definition and associations of insulin resistance","volume":"48","author":"Mojiminiyi","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jc.85.7.2402","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1517\/14656566.2010.489553","article-title":"Lipid-lowering agents and new onset diabetes mellitus","volume":"11","author":"Athyros","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.2174\/138161210794455085","article-title":"Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?","volume":"16","author":"Athyros","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2362.2005.01549.x","article-title":"Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia","volume":"35","author":"ter Avest","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/000331970505600510","article-title":"Starting with rosuvastatin in primary hyperlipidemia-is there more than lipid lowering?","volume":"56","author":"Milionis","year":"2005","journal-title":"Angiology"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.atherosclerosis.2009.11.021","article-title":"Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes","volume":"210","author":"Bellia","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1742-1241.2009.02101.x","article-title":"Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose","volume":"63","author":"Kostapanos","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF03345565","article-title":"Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic type 2 diabetes","volume":"31","author":"Chu","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2006.01.055","article-title":"Effect of atorvastatin (10\u2003mg\/day) on glucose metabolism in patients with the metabolic syndrome","volume":"98","author":"Huptas","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients","volume":"55","author":"Koh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s11095-008-9798-6","article-title":"Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia","volume":"26","author":"Qu","year":"2009","journal-title":"Pharm Res"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.numecd.2008.11.008","article-title":"Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment","volume":"19","author":"Arca","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.metabol.2008.07.030","article-title":"Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia","volume":"57","author":"Hyogo","year":"2008","journal-title":"Metabolism"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2337\/diacare.28.3.754","article-title":"Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes","volume":"28","author":"von Eynatten","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.jhh.1002201","article-title":"Validity and reproducibility of HOMA-IR, 1\/HOMA-IR, QUICKI and McAuley\u2019s indices in patients with hypertension and type II diabetes","volume":"21","author":"Sarafidis","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.1111\/j.1742-1241.2011.02655.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.diabet.2008.02.001","article-title":"HOMA or QUICKI: is it useful to test the reproducibility of formulas?","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab"}],"container-title":"International Journal of Clinical Practice","original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02655.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:09:07Z","timestamp":1497917347000},"score":1.0,"subtitle":["Impact of statins on glucose metabolism"],"short-title":[],"issued":{"date-parts":[[2011,5,12]]},"references-count":28,"journal-issue":{"published-print":{"date-parts":[[2011,6]]},"issue":"6"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1742-1241.2011.02655.x","relation":{"cites":[]},"ISSN":["1368-5031"],"subject":["General Medicine"]}